A new Cochrane review confirms that antidepressants effectively reduce symptoms of generalized anxiety disorder (GAD) under trial conditions, although there is limited data on long-term usage.
A new Cochrane review confirms that antidepressants effectively reduce symptoms of generalized anxiety disorder (GAD) under ...
Inc. stock despite strong Phase 2b data. Click for my updated look at MNMD stock and its market opportunities.
What if the key to reducing stress and anxiety lies in how you view your challenges? Based on cognitive reframing practices, ...
Shortness of breath, or dyspnea, is an anxiety symptom that can be triggered by certain, anxiety-inducing situations. Here’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback